CanMED: NDC

Drug Name (Brand or Generic) Separate terms with OR to return results that match either term.

Major Class

Package in use from (mm/dd/yyyy):

To:

SEER*Rx Category

Clear All

10,000 Matching Results — Export these results

Click column titles once to sort ascending, and twice to sort descending.

Show Entries

NDC-11 (Package)	NDC-9 (Product)	Generic Name	Brand Name	Strength	SEER*Rx Category	Major Class (Descending)	Minor Class	Administration Route	Package Effective Date	Status
43598-0392-48	43598-0392	Melphalan Hydrochloride	Melphalan Hydrochloride		Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous	Dec. 18, 2017	In Use
70121-1244-07	70121-1244	Busulfan	Busulfan	6.0 mg/mL	Chemotherapy	Alkylating Agent	Alkylsulfonate	Intravenous	Dec. 18, 2017	In Use
43598-0650-11	43598-0650	Thiotepa	Thiotepa	15.0 mg/1	Chemotherapy	Alkylating Agent	Nitrogen Mustard /Ethylenimine	Intracavitary, Intravenous, Intravesical	May 4, 2018	In Use
70121-1240-01	70121-1240	Cyclophosphamide	Cyclophosphamide	2.0 g/100mL	Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous, Oral	May 31, 2018	In Use
70121-1239-01	70121-1239	Cyclophosphamide	Cyclophosphamide	1.0 g/50mL	Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous, Oral	May 31, 2018	In Use
70121-1238-01	70121-1238	Cyclophosphamide	Cyclophosphamide	500.0 mg/25mL	Chemotherapy	Alkylating Agent	Nitrogen Mustard	Intravenous, Oral	May 31, 2018	In Use
16729-0332-03	16729-0332	OXALIPLATIN	OXALIPLATIN	5.0 mg/mL	Chemotherapy	Alkylating Agent	Platinum Compound	Intravenous	May 17, 2018	In Use
16729-0332-05	16729-0332	OXALIPLATIN	OXALIPLATIN	5.0 mg/mL	Chemotherapy	Alkylating Agent	Platinum Compound	Intravenous	May 17, 2018	In Use
00409-1112-01	00409-1112	Busulfan	Busulfan	6.0 mg/mL	Chemotherapy	Alkylating Agent	Alkylsulfonate	Intravenous	Feb. 28, 2019	In Use
44567-0530-01	44567-0530	cisplatin	Cisplatin	1.0 mg/mL	Chemotherapy	Alkylating Agent	Platinum Compound	Intravenous	April 5, 2019	In Use
00703-4636-01	00703-4636	Streptozocin	Zanosar	100.0 mg/mL	Chemotherapy	Alkylating Agent	Nitrosourea	Intravenous	Dec. 3, 2003	In Use
16729-0048-53	16729-0048	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0048-54	16729-0048	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0050-53	16729-0050	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0050-54	16729-0050	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0051-53	16729-0051	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0129-53	16729-0129	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0129-54	16729-0129	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0130-53	16729-0130	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
16729-0130-54	16729-0130	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	March 7, 2017	In Use
40051-0604-11	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0604-12	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0604-13	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0604-51	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0604-52	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0604-53	40051-0604	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0605-11	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0605-12	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0605-13	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0605-51	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0605-52	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0605-53	40051-0605	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0606-11	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0606-12	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0606-13	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0606-51	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0606-52	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0606-53	40051-0606	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0607-11	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0607-12	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0607-13	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0607-51	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0607-52	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0607-53	40051-0607	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0608-11	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0608-12	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0608-13	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0608-51	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0608-52	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0608-53	40051-0608	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0609-11	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0609-12	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0609-13	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0609-51	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0609-52	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
40051-0609-53	40051-0609	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Aug. 1, 2016	In Use
47335-0893-21	47335-0893	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Feb. 13, 2014	In Use
47335-0893-74	47335-0893	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Feb. 13, 2014	In Use
47335-0893-75	47335-0893	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Feb. 13, 2014	In Use
47335-0893-80	47335-0893	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Feb. 13, 2014	In Use
47335-0893-87	47335-0893	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Feb. 13, 2014	In Use
54868-4142-00	54868-4142	Temozolomide	Temodar	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	June 29, 2005	In Use
54868-4142-02	54868-4142	Temozolomide	Temodar	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	June 29, 2005	In Use
54868-4142-03	54868-4142	Temozolomide	Temodar	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	June 29, 2005	In Use
54868-4142-04	54868-4142	Temozolomide	Temodar	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	June 29, 2005	In Use
54868-4142-05	54868-4142	Temozolomide	Temodar	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	June 29, 2005	In Use
54868-4142-06	54868-4142	Temozolomide	Temodar	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	June 29, 2005	In Use
54868-5348-01	54868-5348	Temozolomide	Temodar	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Oct. 20, 2005	In Use
54868-5350-00	54868-5350	Temozolomide	Temodar	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Oct. 7, 2005	In Use
54868-5350-02	54868-5350	Temozolomide	Temodar	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Oct. 7, 2005	In Use
54868-5350-03	54868-5350	Temozolomide	Temodar	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Oct. 7, 2005	In Use
54868-5350-04	54868-5350	Temozolomide	Temodar	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Oct. 7, 2005	In Use
54868-5354-00	54868-5354	Temozolomide	Temodar	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2006	In Use
54868-5980-00	54868-5980	Temozolomide	Temodar	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	Jan. 26, 2009	In Use
64144-0501-01	64144-0501	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0501-02	64144-0501	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0502-01	64144-0502	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0502-02	64144-0502	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0503-01	64144-0503	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0503-02	64144-0503	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0504-01	64144-0504	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0504-02	64144-0504	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0505-01	64144-0505	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0505-02	64144-0505	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
64144-0506-01	64144-0506	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 13, 2016	In Use
65162-0801-14	65162-0801	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0801-51	65162-0801	Temozolomide	Temozolomide	5.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0802-14	65162-0802	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0802-51	65162-0802	Temozolomide	Temozolomide	20.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0803-14	65162-0803	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0803-51	65162-0803	Temozolomide	Temozolomide	100.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0804-14	65162-0804	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0804-51	65162-0804	Temozolomide	Temozolomide	140.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0805-14	65162-0805	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0805-51	65162-0805	Temozolomide	Temozolomide	180.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
65162-0806-51	65162-0806	Temozolomide	Temozolomide	250.0 mg/1	Chemotherapy	Alkylating Agent	Tetrazine	Oral	April 3, 2015	In Use
00143-9565-01	00143-9565	Thiotepa	Thiotepa	15.0 mg/1.5mL	Chemotherapy	Alkylating Agent	Nitrogen Mustard /Ethylenimine	Intracavitary, Intravenous, Intravesical	June 1, 2001	In Use
59676-0610-01	59676-0610	Trabectedin	Yondelis	0.05 mg/mL	Chemotherapy	Alkylating Agent	Natural Product	Intravenous	Oct. 23, 2015	In Use
71288-0126-90	71288-0126	Carmustine	Carmustine		Chemotherapy	Alkylating Agent	Nitrosourea	Intravenous	Aug. 2, 2021	In Use
43598-0628-57	43598-0628	Carmustine	Carmustine		Chemotherapy	Alkylating Agent	Nitrosourea	Intravenous	Oct. 4, 2021	In Use

Found 10,000 results in 9 milliseconds — Export these results

CanMED and the Oncology Toolbox

CanMED: NDC